The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.
The global In Vivo Toxicology market was valued at US$ 4194.4 million in 2023 and is anticipated to reach US$ 6164 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
North American market for In Vivo Toxicology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vivo Toxicology is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for In Vivo Toxicology in Immunotoxicity is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of In Vivo Toxicology include Thermo Fisher Scientific, Danaher, Charles River Laboratories, Labcorp, The Jackson Laboratory, Data Sciences International, Envigo, Eurofins Scientific and Perkinelmer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vivo Toxicology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo Toxicology.
Report Scope
The In Vivo Toxicology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vivo Toxicology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vivo Toxicology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Thermo Fisher Scientific
- Danaher
- Charles River Laboratories
- Labcorp
- The Jackson Laboratory
- Data Sciences International
- Envigo
- Eurofins Scientific
- Perkinelmer
- SRI International
- Taconic Biosciences
- Wuxi Apptec
Segment by Type
- Chronic Toxicity Testing
- Sub-Chronic Toxicity Testing
- Sub-Acute Toxicity Testing
- Acute Toxicity Testing
Segment by Application
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity(DART)
- Other Toxicity Endpoints
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vivo Toxicology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Toxicology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chronic Toxicity Testing
1.2.3 Sub-Chronic Toxicity Testing
1.2.4 Sub-Acute Toxicity Testing
1.2.5 Acute Toxicity Testing
1.3 Market by Application
1.3.1 Global In Vivo Toxicology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Immunotoxicity
1.3.3 Systemic Toxicity
1.3.4 Carcinogenicity
1.3.5 Genotoxicity
1.3.6 Developmental and Reproductive Toxicity(DART)
1.3.7 Other Toxicity Endpoints
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Toxicology Market Perspective (2019-2030)
2.2 In Vivo Toxicology Growth Trends by Region
2.2.1 Global In Vivo Toxicology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vivo Toxicology Historic Market Size by Region (2019-2024)
2.2.3 In Vivo Toxicology Forecasted Market Size by Region (2025-2030)
2.3 In Vivo Toxicology Market Dynamics
2.3.1 In Vivo Toxicology Industry Trends
2.3.2 In Vivo Toxicology Market Drivers
2.3.3 In Vivo Toxicology Market Challenges
2.3.4 In Vivo Toxicology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Toxicology Players by Revenue
3.1.1 Global Top In Vivo Toxicology Players by Revenue (2019-2024)
3.1.2 Global In Vivo Toxicology Revenue Market Share by Players (2019-2024)
3.2 Global In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vivo Toxicology Revenue
3.4 Global In Vivo Toxicology Market Concentration Ratio
3.4.1 Global In Vivo Toxicology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Toxicology Revenue in 2023
3.5 In Vivo Toxicology Key Players Head office and Area Served
3.6 Key Players In Vivo Toxicology Product Solution and Service
3.7 Date of Enter into In Vivo Toxicology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo Toxicology Breakdown Data by Type
4.1 Global In Vivo Toxicology Historic Market Size by Type (2019-2024)
4.2 Global In Vivo Toxicology Forecasted Market Size by Type (2025-2030)
5 In Vivo Toxicology Breakdown Data by Application
5.1 Global In Vivo Toxicology Historic Market Size by Application (2019-2024)
5.2 Global In Vivo Toxicology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vivo Toxicology Market Size (2019-2030)
6.2 North America In Vivo Toxicology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vivo Toxicology Market Size by Country (2019-2024)
6.4 North America In Vivo Toxicology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo Toxicology Market Size (2019-2030)
7.2 Europe In Vivo Toxicology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vivo Toxicology Market Size by Country (2019-2024)
7.4 Europe In Vivo Toxicology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Toxicology Market Size (2019-2030)
8.2 Asia-Pacific In Vivo Toxicology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vivo Toxicology Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vivo Toxicology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo Toxicology Market Size (2019-2030)
9.2 Latin America In Vivo Toxicology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vivo Toxicology Market Size by Country (2019-2024)
9.4 Latin America In Vivo Toxicology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Toxicology Market Size (2019-2030)
10.2 Middle East & Africa In Vivo Toxicology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vivo Toxicology Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vivo Toxicology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific In Vivo Toxicology Introduction
11.1.4 Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher In Vivo Toxicology Introduction
11.2.4 Danaher Revenue in In Vivo Toxicology Business (2019-2024)
11.2.5 Danaher Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Detail
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories In Vivo Toxicology Introduction
11.3.4 Charles River Laboratories Revenue in In Vivo Toxicology Business (2019-2024)
11.3.5 Charles River Laboratories Recent Development
11.4 Labcorp
11.4.1 Labcorp Company Detail
11.4.2 Labcorp Business Overview
11.4.3 Labcorp In Vivo Toxicology Introduction
11.4.4 Labcorp Revenue in In Vivo Toxicology Business (2019-2024)
11.4.5 Labcorp Recent Development
11.5 The Jackson Laboratory
11.5.1 The Jackson Laboratory Company Detail
11.5.2 The Jackson Laboratory Business Overview
11.5.3 The Jackson Laboratory In Vivo Toxicology Introduction
11.5.4 The Jackson Laboratory Revenue in In Vivo Toxicology Business (2019-2024)
11.5.5 The Jackson Laboratory Recent Development
11.6 Data Sciences International
11.6.1 Data Sciences International Company Detail
11.6.2 Data Sciences International Business Overview
11.6.3 Data Sciences International In Vivo Toxicology Introduction
11.6.4 Data Sciences International Revenue in In Vivo Toxicology Business (2019-2024)
11.6.5 Data Sciences International Recent Development
11.7 Envigo
11.7.1 Envigo Company Detail
11.7.2 Envigo Business Overview
11.7.3 Envigo In Vivo Toxicology Introduction
11.7.4 Envigo Revenue in In Vivo Toxicology Business (2019-2024)
11.7.5 Envigo Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific In Vivo Toxicology Introduction
11.8.4 Eurofins Scientific Revenue in In Vivo Toxicology Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Perkinelmer
11.9.1 Perkinelmer Company Detail
11.9.2 Perkinelmer Business Overview
11.9.3 Perkinelmer In Vivo Toxicology Introduction
11.9.4 Perkinelmer Revenue in In Vivo Toxicology Business (2019-2024)
11.9.5 Perkinelmer Recent Development
11.10 SRI International
11.10.1 SRI International Company Detail
11.10.2 SRI International Business Overview
11.10.3 SRI International In Vivo Toxicology Introduction
11.10.4 SRI International Revenue in In Vivo Toxicology Business (2019-2024)
11.10.5 SRI International Recent Development
11.11 Taconic Biosciences
11.11.1 Taconic Biosciences Company Detail
11.11.2 Taconic Biosciences Business Overview
11.11.3 Taconic Biosciences In Vivo Toxicology Introduction
11.11.4 Taconic Biosciences Revenue in In Vivo Toxicology Business (2019-2024)
11.11.5 Taconic Biosciences Recent Development
11.12 Wuxi Apptec
11.12.1 Wuxi Apptec Company Detail
11.12.2 Wuxi Apptec Business Overview
11.12.3 Wuxi Apptec In Vivo Toxicology Introduction
11.12.4 Wuxi Apptec Revenue in In Vivo Toxicology Business (2019-2024)
11.12.5 Wuxi Apptec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
